Family Medicine Doctors in Ankeny, IA Accepting Medicare

44 Family Medicine doctors found. Showing 41 - 44

Jean Paul, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 E. First Street, Suite 1700, Ankeny, IA 50021 Phone: 515-643-8100    Fax: 515-643-8139

Dr. Kimberly C Bina, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2214 Sw Ridgeway Ct, Ankeny, IA 50023 Phone: 515-963-5450

Dr. Michael Weston Sinklier, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1410 Sw Tradition Dr Ste 120, Ankeny, IA 50023 Phone: 515-875-9040    Fax: 515-875-9041

Craig Scott Gerhart, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 215 Sw Walnut, Ankeny, IA 50023 Phone: 515-964-7965    Fax: 515-964-8937

News Archive

Hope for cure for insulin-dependent diabetes

A diagnosis of type I diabetes means a life sentence of medical follow-up. While treatments have become simpler and less restrictive in recent years, they are still a burden, especially for young patients.

New low-cost COVID-19 test quickly delivers accurate results

A new low-cost diagnostic test for coronavirus disease 2019 (COVID-19) quickly delivers accurate results without the need for sophisticated equipment, according to a study published August 27 2020 in the open-access journal PLOS Pathogens by Teng Xu of the Vision Medicals Center for Infectious Diseases, Tieying Hou of the Guangdong Academy of Medical Sciences, Bing Gu of the Affiliated Hospital of Xuzhou Medical University, Jianwei Wang of the Chinese Academy of Medical Sciences and Peking Union Medical College, and colleagues.

IncellDx, Enzo Clinical Labs sign deal to market proprietary HPV OncoTect technology

Enzo Biochem Inc., as part of its continuing program to offer novel molecular tests, announced that its Enzo Clinical Labs subsidiary has reached an agreement with IncellDx Inc. of Menlo Park, CA, for the rights to market a proprietary laboratory test.

Fetal and neonatal therapy combination may lessen the aftereffects of congenital CMV infection

A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.

Samsung Bioepis submits second biosimilar candidate MAA to EMA

Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization Application (MAA) for SB2, its Remicade (Infliximab) biosimilar candidate, has been submitted to the European Medicines Agency (EMA).

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3(current)